Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0L2XO
|
|||
| Former ID |
DNC000280
|
|||
| Drug Name |
BAY11-7082
|
|||
| Synonyms |
bay 11-7082; 19542-67-7; (E)-3-Tosylacrylonitrile; Bay 11-7821; (E)-3-(p-Toluenesulfonyl)acrylonitrile; BAY-11-7082; BAY11-7082; UNII-4Y5G2A4F6O; BAY-11-7821; (E)-3-(4-Methylphenyl)sulfonylprop-2-enenitrile; BAY-117082; BAY-117821; CHEMBL403183; 4Y5G2A4F6O; 3-(4-methylphenylsulfonyl)-2-propenenitrile; CHEBI:85928; 3-[(4-methylphenyl)sulfonyl]prop-2-enenitrile; AK129348; (E)-3-(4-Methylphenylsulfonyl)-2-propenenitrile; (E)3-[(4-Methylphenyl)sulfonyl]-2-propenenitrile; J-501956; (2E)-3-[(4-methylphenyl)sulfonyl]prop-2-enenitrile
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Multiple myeloma [ICD-11: 2A83; ICD-10: C90.0] | Investigative | [1] | |
| Company |
Biomol
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C10H9NO2S
|
|||
| Canonical SMILES |
CC1=CC=C(C=C1)S(=O)(=O)C=CC#N
|
|||
| InChI |
1S/C10H9NO2S/c1-9-3-5-10(6-4-9)14(12,13)8-2-7-11/h2-6,8H,1H3/b8-2+
|
|||
| InChIKey |
DOEWDSDBFRHVAP-KRXBUXKQSA-N
|
|||
| CAS Number |
CAS 19542-67-7
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
10852036, 11651295, 12105749, 15171849, 24891842, 26752238, 26752239, 26758287, 39379620, 47291238, 47736600, 47810867, 47810868, 48035248, 48259357, 50104945, 53789942, 57361538, 79013456, 85147456, 85787778, 87917009, 90341543, 92310125, 99291881, 99301037, 99302557, 99302645, 103127505, 103574750, 104051649, 106708809, 113909214, 117629502, 118402556, 121270652, 121361981, 124658761, 126602149, 131299048, 131303955, 131404639, 134345379, 134964457, 135353655, 135727354, 136345223, 137030529, 142752500, 143985762
|
|||
| ChEBI ID |
CHEBI:85928
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5934). | |||
| REF 2 | Emerging therapies for multiple myeloma. Expert Opin Emerg Drugs. 2009 Mar;14(1):99-127. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.